[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:pole-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"POLE Gene",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05640999","Adjuvant Therapy in POLE-Mutated and p53-Wildtype\u002FNSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER",[11],"Phase 2","RECRUITING","2026-08-26T02:16:24.135291Z","2026-05-05T02:43:28.517766Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT04774419","Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery",[11],"2026-08-26T02:15:48.613507Z","2026-05-05T02:43:28.401063Z"]